Regarding the immunopathological mechanisms in rheumatoid arthritis, all of the following are true EXCEPT:

Explanation

## Immunopathological Mechanisms in Rheumatoid Arthritis ### Key Autoimmune Features **Key Point:** The immunopathology of RA involves multiple layers of adaptive and innate immune activation, centered on loss of tolerance to self-antigens and formation of pathogenic immune complexes. ### Autoantibodies in RA | Autoantibody | Target | Clinical Significance | |---|---|---| | Rheumatoid Factor (RF) | Fc portion of IgG | Present in ~80% of RA; can be IgM, IgG, or IgA | | Anti-CCP | Citrullinated proteins | ~95% specific for RA; predicts erosive disease and poor prognosis | | Anti-dsDNA | Double-stranded DNA | More specific for SLE; NOT typical of RA | **High-Yield:** Anti-CCP antibodies are superior to RF for early diagnosis and prognostication in RA because they appear earlier in disease course and correlate with radiographic progression. ### Th17 Cell Axis in RA **Key Point:** IL-17-producing T helper cells (Th17) are a critical driver of synovial inflammation in RA: - Th17 cells are differentiated from naïve T cells by IL-6 and TGF-β - IL-17 recruits neutrophils and activates synovial fibroblasts - IL-17 also promotes osteoclast differentiation via RANKL upregulation, leading to bone erosion ### Immune Complex Composition — The Distractor **Warning:** The incorrect option claims immune complexes are "IgA-dominant" and activate complement "exclusively through the alternative pathway." This is FALSE: 1. **Dominant Immunoglobulin Class:** Immune complexes in RA are predominantly **IgG and IgM**, not IgA. IgA-dominant immune complexes are characteristic of IgA nephropathy (in the kidney) and IgA vasculitis, NOT RA. 2. **Complement Activation Pathway:** RA immune complexes activate complement through **both classical and alternative pathways**: - Classical pathway: IgG and IgM in immune complexes bind C1q directly - Alternative pathway: Amplification loop is activated secondarily - NOT exclusively alternative pathway 3. **Clinical Consequence:** Complement activation (especially C3a, C5a) drives recruitment of neutrophils and macrophages into the synovium, perpetuating inflammation. **Clinical Pearl:** Low serum complement (C3, C4) in RA indicates active immune complex disease and correlates with systemic manifestations (vasculitis, pericarditis). ### Summary of Correct Statements - **Option 1 (TRUE):** RF is indeed an IgM autoantibody against IgG Fc region—classic definition. - **Option 2 (TRUE):** Anti-CCP is more specific (~95%) than RF (~80%) and is the best predictor of erosive RA. - **Option 3 (TRUE):** Th17 cells and IL-17 are central to synovial inflammation and osteoclast activation via RANKL. - **Option 4 (FALSE):** Immune complexes are IgG/IgM-dominant (not IgA) and activate complement via classical pathway (not exclusively alternative).